No Data
No Data
Pfizer Options Spot-On: On May 7th, 106.28K Contracts Were Traded, With 3.48 Million Open Interest
Jim Cramer on Pfizer (PFE): "Trying Big Targets, but New Wins Still Elusive"
Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says -- Barrons.com
Pfizer, J&J, Genentech Drugs Subject of FDA Advisory Panel Meeting This Month
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Daily short sale tracking: Palantir's short volume increased by 10 million, with a short sale ratio of 12%